informa
2 MIN READ
News

Imprivata Adds User Validation

Imprivata announced ProveID for OneSign

LEXINGTON, Mass. -- Imprivata®, Inc., the enterprise identity and access management appliance company, today announced ProveIDTM for OneSign, a new functionality within OneSign that provides the means to insert transactional strong authentication into any application’s workflow, addressing increasing policy and regulatory compliance requirements being mandated in numerous industries, states and countries. ProveID, in combination with any application, can ensure transactions are properly and traceably authenticated, eliminating compliance and policy risks including unauthorized data transfers, complicated workflows and illegitimate or erroneous transactions or activities.

“As identity-based regulations become more common and stringent across many industries, transactional strong authentication will be the norm in any situation where a person’s identity is an important element of a transaction,” said Omar Hussain, president and CEO of Imprivata. “OneSign has been overwhelmingly accepted in a wide range of industries as an easy to use and implement identity, authentication and password management platform. Tightly integrating OneSign’s authentication management capability with applications’ transactions helps organizations meet regulations or simply institute good risk management.”

Imprivata’s ProveID allows customers and independent software vendors to use OneSign’s core functionality within their applications, thereby simplifying workflows, providing clear audit trails and minimizing risk of errors, unauthorized access and system abuse. The needs for this technology are broad and include sensitive human resource tasks, drug ordering and handling, warehouse inventory management and tracking transactions in retail or institutional banking.

ProveID addresses customer demand in response to increasing regulatory pressures, such as the state of Ohio Board of Pharmacy’s requirement for two-factor authentication for controlled drug prescription orders. The authentication requirements may include countersigning, multifactor authentication or strong passwords to bolster policy enforcement and compliance where these efforts are most important – immediately prior to completing the transaction. OhioHealth, a family of not-for-profit, faith-based hospitals and healthcare organizations, is utilizing the OneSign’s ProveID functionality in conjunction with McKesson’s Horizon Expert Orders and Horizon Emergency Care solutions to meet the state requirement for transactional strong authentication.

“With the technology available today, it is possible to run a digital facility -- something we will accomplish in Dublin, Ohio within the year. While we are making this transition, we are also facing increasing regulations requiring transaction-specific two-factor identification for drug orders,” said Lamont Yoder, vice president and chief nursing officer RN, MBA, CNAA, FACHE at Dublin Methodist Hospital, OhioHealth. “With ProveID we can make the leap to digital workflows knowing that we will easily meet this requirement and our security will be stronger than ever before.”

Imprivata Inc.

Editors' Choice
Robert Lemos, Contributing Writer, Dark Reading
Robert Lemos, Contributing Writer, Dark Reading
Dark Reading Staff, Dark Reading
Jai Vijayan, Contributing Writer, Dark Reading